328 related articles for article (PubMed ID: 11227650)
1. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
[TBL] [Abstract][Full Text] [Related]
2. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
[TBL] [Abstract][Full Text] [Related]
3. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
[TBL] [Abstract][Full Text] [Related]
4. Medical therapy to reduce postoperative Crohn's disease recurrence.
Achkar JP; Hanauer SB
Am J Gastroenterol; 2000 May; 95(5):1139-46. PubMed ID: 10811318
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
Papamichael K; Archavlis E; Lariou C; Mantzaris GJ
J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843
[TBL] [Abstract][Full Text] [Related]
6. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
[TBL] [Abstract][Full Text] [Related]
7. [Azathioprine for prevention of postoperative recurrence in Crohn's disease].
Abdelli MN; Ben Abdallah H; Houissa F; Bouali MR; Khediri MF
Tunis Med; 2007 Jul; 85(7):569-72. PubMed ID: 18064988
[TBL] [Abstract][Full Text] [Related]
8. [5-Aminosalicylic acid in the prevention of recurrences of Crohn's disease].
Del Corso L; Moruzzo D; Romanelli AM; Norpoth M; Pentimone F; Bresci G
Dtsch Med Wochenschr; 1995 Dec; 120(50):1723-7. PubMed ID: 8542807
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
10. Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease.
Klein O; Colombel JF; Lescut D; Gambiez L; Desreumaux P; Quandalle P; Cortot A
Am J Gastroenterol; 1995 Nov; 90(11):1949-52. PubMed ID: 7484997
[TBL] [Abstract][Full Text] [Related]
11. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
Kim PS; Zlatanic J; Korelitz BI; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
[TBL] [Abstract][Full Text] [Related]
12. Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.
Frieri G; Pimpo MT; Palumbo G; Tonelli F; Annese V; Sturniolo GC; Andreoli A; Comberlato M; Corrao G; Caprilli R
Am J Gastroenterol; 2000 Jun; 95(6):1486-90. PubMed ID: 10894584
[TBL] [Abstract][Full Text] [Related]
13. Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. International Mesalazine Study Group.
Aliment Pharmacol Ther; 1990 Feb; 4(1):55-64. PubMed ID: 2104074
[TBL] [Abstract][Full Text] [Related]
14. Current treatment for prevention of relapse and recurrence in Crohn's disease.
Prantera C; Scribano ML
Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
Ford AC
Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
[No Abstract] [Full Text] [Related]
16. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
Reinisch W; Stange EF;
Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
[No Abstract] [Full Text] [Related]
17. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
18. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
19. [Postoperative recurrence in Crohn's disease].
Caprilli R; Taddei G; Viscido A
Chir Ital; 1995; 47(5):25-32. PubMed ID: 9162601
[TBL] [Abstract][Full Text] [Related]
20. Addition of mesalazine for subclinical post-surgical endoscopic recurrence of Crohn's disease despite preventive thiopurine therapy: A case-control study.
Zabana Y; Mañosa M; Cabré E; Bernal I; Marín L; Lorenzo-Zúñiga V; Moreno V; Boix J; Domènech E
J Gastroenterol Hepatol; 2014; 29(7):1413-7. PubMed ID: 24627958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
